Philip Morris
Clarification and Standardization of Substance Abuse Terminology
Fields
- Author
- Goodwin, D.
- Rinaldi, R.C.
- Steindler, E.M.
- Wilford, B.B.
- Type
- PUBL, PUBLICATION, OTHER
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Site
- N403
- Named Organization
- Ama, Ama
- American Academy of Pediatrics
- American Assn for Counseling + Develop
- American College of Health Assn
- American College of Physicians
- American College of Preventive Medicine
- American Medical Society on Alcoholism
- American Psychiatric Assn
- American Psychological Assn
- American Society for Clinical Pharmacolo
- American Society of Clincal Pathologies
- American Society of Internal Medicine
- Assn for Medical Education + Research in
- Assn of Labor Management Administration
- Il Dept of Public Health
- Journal of the American Medical Assn
- Natl Assn of Social Workers
- Natl Assn of State Alcohol + Drug Abuse
- Natl Federation of Parents for Drug Free
- Research Society on Alcoholism
- Task Force
- Vieta Hill Foundation
- Who, World Health Org
- Alcoholism + Addiction Research Foundati
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Named Person
- Blume, S.B.
- Cohen, S.
- Gitlou, S.E.
- Lundberg, G.D.
- Master ID
- 2046398862/0490
- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399396-9419 Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
Related Documents:
Document Images
I
I
I
I
I
I
I
I
I
I
I
I
I
I
~
I
I
Preliminary Communication
Clarification and Standardization
of Substance Abuse Terminology
flobert C. Rinaldi, PhD, Emanual M. Steindler. MS; Bonnie B. Wilford: pesiree Goodwin, MPA
A four-stage Delphi survey of substance abuse ecperts was conducted to help
achieve greater clarity and uniformity in terminology associated with alcohol
and other drug-related problems. This multidisciplinary group of experts was
asked to reach a consensus on alcohol and other drug-related terms and
definitrons. Results produced a list of 50 substance abuse terms deemed
important, along with the most agreed on definition for each term.
(JAMA iNSZ-9-.sassa7)
IN AUGUST 1983, the American Med-
ical Associations (AMA's) Council on
Scientific Affairs' Panels on Alcoholism
and Drug Abuse considered the need
for providing greater clarity and uni-
formity in the terminology associated
with substance abuse disorders. It was
recommended that a task force be es-
tablished to develop standard defini-
tions .
Once constituted, the Task Force de-
termined to collect data from a cross-
disciplinary group of researchers, clini-
cians, administrators, and academicians
in the field of substance abuse. The
Delphi technique, a method for eliciting
opinions from experts to reach a com-
monh accepted view was used.
This report provides a description of
the Delphi process used, definitions for
50 drug- and alcohol-related terms as
developed and agreed on by the sub-
stance abuse experts, and comments on
each definition by the Task Fbrce.
(Members of the Task Fbrce were the
late Sidney Cohen. MD, Chairman,
Sheila B. Blume, MD, Stanley E. Git-
1ow, MD, and George D. Ltuydberg, MD. )
TERMINOLOGY
Problems of terminology and classifi-
cation related to the use of psychoactive
drugs are long-standing.- As early as
1952, the World Health Organization
(WHO) acknowledged difficulties in this
field and attempted to develop a defini-
P+om mrDeo.mmerxs a M«w, M.aro, (or wn.a,
Ak St.moKr .no Mt Gootlwml.no subaanct Abus~
(MS WMtYO~ Arten04n MeCcv MiOCytcl ChC&qo
Fra+rn ieouesn m Dso.R++r}x a M.rxs, mam+
AnKmw AMdca' AuouuKn 535 N purDOm Stt
crrapo. IL ios,o (Dr Rw0)
tion of "addiction' that could be applied
to drugs then under international con-
trol.' In 1957, a WHO expert committee
introduced nomenclature to distinguish
between "addiction" and "habituation,'
but in practice, this terminology led to
confusion.4 The next attempt at clarifi-
cation came in 1964, when the same
WHO committee recommended substi-
tution of the word "dependence" for
both "addiction" and "habituation."'
Several dilSculties arise from the lack
of consensus on a substance abuse lex-
icon. First, an array of concepts and
terms is in active use. Second, a variety
of professional disciplines are involved
in research, treaunent, and education
regarding alcohol- and other drug-re-
lated problems, with each discipline
tending to utilize different terms The
lack of precise definitions and universal
agreement on language has hampered
effective communication among profes-
sionals.' Finallx for public policy and
third-party reimbursement purposes,
the confusing panoply of terms and
definitions has tended to impede under-
standing and appropriate responses
A,dvances in claasifuation and nomen-
clature are needed in dealing with the
major public health problems posed by
excessive use of alcohol and other
drugs' Such advances are required to
fac9litate research and analysis, provide
a better understanding of disease eti-
ology, and improve management and
decision mr.king in clinical treatment'4~_'
METNOOS
The research method used in this
study was the Delphi technique, a mul-
tiple-atage survey processintended to
produce a consensus. Information is
obtained from a defined target group
JAMA. .lin 2?J29. 1988-1bt 259. No 4
Ubl. t .-Peo/wmrt Orqsnueon A.Msknnc
tn sa,ay
Ar+rncan M.draiA..oo.na,
NoohoMre, r,a AadKeon r+....ra+ c«.+o.oon
/4,wnun Ameuny a r.a.~
Artw+eo n M.ooeeon br c*~rq r+e
Mw+on~cowoA a Hwn Awoaeeon
MWcen cowqp a P*ryo.ru
MwCan cowp~ a rwr.nov.
4nrne.n r.aer soaay on " or.n tr,e
M+w+cr+ Nus~s b.oo.oon k+c
N"Snomm Mwm* + P M.oaaon
An,N,cyn sawty br crrer Pt~.rnroowpy
Anw,ema a..DW Pas~doqa>:
Mw+ean Booeb 01 k+1.ma fAedieier
A.roor.on br M.e" EouaMn .ne fin..rv,
n aubWnn Aeum
A.woson ol L4bor M.raQorrwx Aanrrseaem+ v+d
corw~ltrea+ a+ Akohoksm Wc
dounw a.» Am«rcan M.acy Auoa.eon
r.101i o.o.rb}wfu of PUbYC hl.an+
Npa,r At.oa.0oe, a anS. Alca+a ve
n
a sxw wax.o
t w A. ~ ~
n ioa.ao ~
Mataw P.ftr.om, a P.r.ns br aup ir.. Kx,e+
ii.wrsh SoaMy on A~oona~m
ViW fYll i~
and resubmitted to that group for rank-
ing, rating. or both.'
The Delphi technique is well suited
to drawing unpublished technical and
scientific information from experts.' It
assures anonymity and, thus, enhances
the participants' ability to make state-
ments disregarding expressed public
opinion and eliminating peer pressure.
In this studx a pool of experts was
established by requesting nominees
with drug- and alcohol-related exper-
tise from among the membership of
appropriate professional organizations
(Table 1). From this poo1, 99 experts
from 23 organizations representing rel-
evant disciplines and professions were
nominated Mble 2).
Four rounds of data gathering were
conducted: (1) A list of terms was col-
lected, (2) the terms were rank ordered,
(3) definitions were assigned to the
terms, and (4) the definitions were rank
ordered. Both AMA staff and Task
Force members were involved in con-
densing, editing, and combining like
terms between rounds of data collection
to keep the project at a manageable
level.
subsunce abuse-R naitl ec 81 SSS

I
I
I
I
I
I
I
I
I
I
I
I
I
I
TabN 2-Prof*SsOW D.qrsM R4pre.~ m
Sn+ay
OpeM No a ko/...anus
MO y
ft0 19
MSW 4
RN 3
MSoaMA s
EdD I
Olt+a 13
StaQ. I
In stage 1, a letter explaining the
scope and goals of the project was sent
to the 99 experts nominated by profes-
sional organizations. Each participant
was asked to generate a list of terms
related-but not necessarily limited-
to the diagnosis, treatment, education,
and research of alcohol- and drug-re-
lated problems.
Of the 99 participants contacted, 72
provided lists of terms, four declined
participation, and 23 failed to respond
even after one follow-up telephone call.
This constituted a 77% expert partici-
pant response rate.
More than 1200 terms were submit-
ted. By combining similar terma and
eliminating those judged to be already
well defined, the list was reduced by
approximately two thirds.
Stop 2
In stage 2, the list of 447 terms was
sent to 80 participanta (72 stage 1
respondents and eight original nomi-
nees who sought late admissionk Re-
spondents were asked to rate each term
according to its relative importance to
the field of substance abuse. A six-point
Likert-type summated rating scale was
used, with 6 representing "most impor.
tant," and 1, "least unportant."
After one follow-up telephone call to
nonresponders, 68 completed liata ai^a~e
returned, yielding a response rate of
85%.
Stp. 3
Mean and median scores were calcu-
lated for each ranked term from stage
2. Ninety-three terms reeeived a mean
score of 5 or above, and 23 of these
terms received a median score ot 6.
The 23 terma that received a median
score of 6 were:etained for use in stage
3 in that they formed a "natural gtnup-
ine The remaining terms that received
a mean score of at least 5 were edited
to eliminate duplicates and already well-
defined terms; this process yielded a
complement of 22 term: Five additional
terms that received mean scores of less
than 5 were deemed important enough
by investigators and the Task Fbrce to
include in the final list Thua, a list of
50 terms was compiled.
Participants were then instructeo to
define each of the 50 top-ranked terms
Ninety-two participants (80 individuals
who were asked to respond in stage 2
plus 12 original nominees who sought
late admission) were asked to respond.
After one follow-up telephone call, 42
completed lists were returned, yielding
a response rate of 46%.
Intermsdlate Sta"
After systematic analysis of stage 3
data, five de8nitions were selected for
each term. With use of a Q-sort rank-
ordering technique, definitions were se-
lected on the basis that they fairly
represented the range of all definitions
submitted for a particular term. In the
process, "drug addict' was subaumed
under "addict," 'drug addiction' under
"addiction," and "drug dependence" un-
der "dependence"
In a continuing effort to keep this
project at a manageable level, Task
Fbrce members were asked to evaluate
and rank the five definitions for each
term based on perceived quality and
usefulness. Mean scores were calculated
on'IUk Fbrce choices to select the three
top-ranked definitions for each term.
StaqO 4
In the fourth round, participants
were sent the list of terms with three
definitions assigned to each. They were
instructed to select one definition con-
sidered best for each term.
Ninety-three participants (92 indivi-
duals who were asked to respond in
stage 3 plus one original nominee who
sought late admission) were asked to
respond. After one follow-up telephone
call, 65 completed lists were returned,
yielding a response rate of 70%.
RESULTS
Itatings for desnttiona .rere sum-
mated acrcas respondents. Those re-
ceiving the greatest number of votes
are listed beloa4 followwg their respeo-
tive terms. This list represents 60 sub-
stance abuse terms deemed important,
with the most agreed on definitions, by
a cross-disciplinary national group of
substance abuse experta (Only 47
terms and definitions appear because
"drug addict" was subeumed under "ad-
W rd2Ug iddiCtloD' under raddlC-
tion," and "drug dependenee" under
"dependeace.") The list includes the
following terms:
Abstinence: Cessation of use of a
psychoactive substance previously
abused, or on which the user has devel-
oped drug dependence.
Abuss PotrRtial: The property of a
substance that, by its physiological or
psychological effects, or both, increases
the likelihood of an individuaih abusing
or becoming dependent on that sub-
stance.
(Drug) Addiet: A person who is phys-
ically dependent on one or more psy-
choactive substances, whose long-term
use has produced tolerance, who has
lost control over his intake, and would
manifest withdrawal phenomena if dis-
continuance were to occur.
(Drug) Addiction: A chronic disorder
characterized by the compulsive use of
a substance resulting in physical. psy-
chological, or social harm to the user
and continued use despite that harm.
Alcohol Abuse: Use of ethyl alcohol
in a quantity and with a frequency that
causes the individual significant physi-
ological, psychological, or sociological
distress or impairment.
Al.cohol Addiction: Physiological and
psychological dependence on alcohol.
Alcohol Dependence: Chronic loss of
control over the consumption of alco-
holic beverages, despite obvious psy-
chological or physical harm to the per-
son. Increasing amounts are required
over time, and abrupt discontinuance
may precipitate a withdrawal syn-
drome. Following abstinence, relapse is
frequent.
Alcoholic: Person who has experi-
enced physical, psychological, social, or
occupational impairment as a conse-
quence of habitual, excessive consunip-
tion of alcohol.
Alcoholics Anonymous: An interna-
tional, nonprofessional organization of
alcohol-dependent persons devoted to
the achievement and maintenance of
sobriety of its members through self-
help and mutual support.
Alcoholism: A chronic, progressive.
and potentially fatal biogenetic and psy-
chosocial disease characterized by tol-
erance and physical dependence mani-
festtd by a loaa of control, as well as
diverse personality changes and social
consequences.
Blackout: Acute anterograde amne-
aia with no formation of long-term mem-
ory, eg a period of memory loss during
which there is no recall for activities,
~ ~from the ingestion of alcohol
drugs.
Cannabis Dependence: The psycha
logical need for a routine pattern of
cannabia use to the point where social-
occupational functioning is impaired to
some degree.
Chemical Dependency: Generic term
relating to psychological or physical
dependency, or both, on an exogenous
substance.
Ckrmac Alcoholisrn: An obsolete
term that should be abandoned. Syn-
onymous with "alcoholism." The con-
trasting term *acute alcoholism' is now
I S5i JAMA. Jan 22/29. 1988-Vb1259. No. 4 Substance Abuse-Ainaid et al

I
p
I
I
I
I
I
I
I
p
I
I
I
I
I
I
I
I
1
rarely used, and means only severe
intoxication by alcohol.
Cross-dependenre: The ability of one
drug to suppress the manifestations of
physical dependence produced by an-
other and to maintain the physically
dependent state.
Cross-tolerance: Tblerance, origi-
nally produced by long-term adminis-
tration of one drug, which is manifested
toward a second drug that has not been
administered previously (eg, tolerance
to alcohol is accompanied by cross-
tolerance to volatile anesthetics or bar-
biturates).
(Drug) Dependence: A generic term
that relates to physical or psychological
dependence, or both. It is characteristic
for each pharmacological class of psy-
choactave drugs. Impaired control over
drug-taldng behavior is implied.
Detosification: A process of with-
drawing a person from an addictive
substance, in a safe and effective man-
ner.
Disease Concept: Recognition that
chemical dependency is a chronic, pro-
gressive, and potentially fatal bioge-
netic and psychosocial disease charac-
terized by tolerance and physical
dependence manifested by a loss of
control, as well as diverse personality
changes and social consequences.
Drug Abuse: Any use of drugs that
causes physical, psychological, eco-
nomic, legal, or social harm to the
individual user or to others affected by
the drug user's behavior.
Drug Free: Ongoing disassociation
from the use of any psychoactive sub-
stance.
Drug 1 ntorication: Changes in phys-
iological functioning, psychological
functioning, mood sutes, or cognitive
processes, or all of these, as a conse-
quence of excessive consumption of a
drug; usually disruptive.
Drug Misuse: Any use of a drug that
varies from a socially or medically ac-
cepted use.
Enabling Behavior: Any action by
another person or an institution that
intentionally or unintentionally has the
effect of facilitating the continuation of
abuse or dependence.
Fhmilial Alcoholism: Pattern of al-
coholism occurring in more than one
generation within a family, due to either
genetic or environmental factors.
Fb.mily Intervention: Specific form of
intervention involving filnily members
of alcohol and drug addicts designed to
benefit the target patient as well as
fan::ly constellation.
Impaired Physician: A physician
whose clinical conduct does not meet
accepted standards of practice and that
is secondary to alcohol-drug use, or
psychiatric illness, or physical illness,
or all three.
Intervention: Act of interceding in
behalf of an individual who is abusing,
or is dependent on. one or more psycho-
active drugs, with the aim of overcoming
denial, interrupting drug-taking behav-
ior, or inducing the individual to seek
and initiate treatment.
Loss of Control: The inability to limit
the use of substances via an internal
locus of control.
Maintenance: A form of therapeutic
intervention applied to opiate addicts,
and consisting of the oral administra-
tion of a substitute opiate drug to min-
imize the reinforcement of drug
and prevent a withdrawal reactio
while permitting rehabilitation to
achieved.
Overdose: The inadvertent or delib-
erate consumption of a much larger dose
than that habitually used by the indi-
vidual in question, and resulting in
serious toxic reactions or death.
Physical Dependence: A physiologi-
cal state of adaptation to a drug or
alcohol, usually characterized by the
development of tolerance to drug effects
and the emergence of a withdrawal
syndrome during prolonged abstinence.
fblydrug Abuse: Concomitant use of
two or more psychoactive substances in
quantities and with frequencies that
cause the individual significant physio-
logical, psychological, or sociological
distress or impairment.
Prevention: Social, economic, legal,
or individual psychological measures
aimed at mininuzing the use of poten-
tially addicting substances, or lowering
the dependence risk in susceptible iur,
dividuals
Primary Prevention: Attempts to re-
duce the incidence of new cases (or
problems) in a general population.
Problem Drinking: (Two definitions
tied for first place): (1) Drinldng pat-
ter:u that have resulted in serious dis-
turbances of health, work, social ad-
justment, or other areas of functionin&
(2) A pattern of alcohol consumption
that does not satisfy all the criteria of
alcoholism, but that is characterized by
sufficiently large intake to have gener-
ated problems of health or social fiulc-
tionin&
Paychologiml Dependence: The emo-
tional state of craving a drug either for
its positive effect or to avoid negative
effects asaociated with its absence.
Recovering Alcoholic: An alcoholic
who is successfully sbstaininir, to em-
phasize the concept that no one is ever
cured, and that recovery must be eon-
tinuously worked at.
Recovery: A process of overcoming
both physiological and psychological de-
pendence on a drug or alcohol.
Rehabilitation: The restoration of an
optimum state of health by medical,
psychological, social, and peer group
support for a chemically dependent per-
son and his significant others.
Relapse: Recurrence of alcohol- or
drug-dependent behavior in an individ-
ual who has previously achieved and
maintained abstinence for a significant
time beyond the period of detoxifica-
tion.
Sobriety: Generally refers to the state
of complete abstinence from alcohol and
other drugs of abuse in conjunction with
a satisfactory quality of life.
Substance Abuse: The use of a psy-
choactive substance in a manner detri-
mental to the individual or society but
not meeting criteria for substance or
drug dependence.
Tbleraxce: Physiological adaptation
to the effect of drugs, so as to diminish
effects with constant dosages or to
maintain the intensity and duration of
effects through increased dosage.
Natmext: Application of planned
procedures to identify and change pat-
terns of behavior that are maladaptive,
destructive, or health injuring; or to
restore appropriate levels of physical,
psychological, or social functioning.
Wilhdrawal: Cessation of drug or .
alcohol use by an individual in whom
dependence is established.
Withdrawal Syndrome: The onset of
a predictable constellation of signs and
symptoms involving altered activity of
the central nervous system after the
abrupt discontinuation oC or rapid de-
crease in, dosage of a drug.
MMe.ne..
1. WHO rspert C.MaitLe oR DMqi Liobl. to
hetree AddiehoR 'IkhaKal RepoR S~riea third
tepat No. 6?. Gesmra. woeld Hsokb or~
~ 0 6spert Ceania.e ae Ad&etio+aHodue
r,yonwL ToduDW aepm saa w.aaa rep«m
No. 116. Geeea. world Hn1W Oetwratwn.1957.
3. rYorid Hnltb Onaniut,ioa: Nomeadaure and
da.&nLion oedtva e+d akoAoi-reLs.d problems:
Sborten.d r.eaom of a WHO sewmnndum. Br J
Ad&d 1f62:TJ3-2D.
4. IVNO Espert Cewwdttee ewAddietioeAodtie
N Gearm iNoeld Halt~ OrPains- 1964.
t. o'Briea x, Cabea S: T'Ik Eweye{ooedis ajDrrp
AkAw. New York. Gnen SW4 lnc. 196/.
i. Hre.a IS F.das! dr+ic P~ ~~':
Fba ex allia' J Nstl X.d Aua 1990:T2:51b581.
t. Chnaeiel TL: lat.eaatiotul atpcets o! probk:ns
woei1t.d .itk the a.e et prydro.eure drum Buil
Nsx 19762935.46.
i. Ilo.eeviee 1. AsmraveK P. SboeteU S. et 91;
}i"kh «rvlee~ naveD tor deaooa o.ke+s: Tr*
um e( the Ddphi uefsniqne to deurmne heakh
19T7s 38~
prioritj.a J NaW Potit tblfey L4w
.10.
9. Hekmr o: A%Wr; of a. tka-: rV oOI*
UAAod. S.nts lioeyea. CatifU tbt RAND Corp.
1f67.
I JAMA. Jan 2?/29. 1 988-Wd 259. No 4 # SubstAn" Abwe-Ama4 01 V SS7
